COPD Clinical Trials in New York, NY

21 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease	Phase 3	AstraZeneca	<1 mi
Evaluation Of The Lung Microbiome In NTM Bronchiectasis	—	NYU Langone Health	<1 mi
SPIROMICS Study of Early COPD Progression (SOURCE)	—	University of Massachusetts, Worcester	<1 mi
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies	—	Weill Medical College of Cornell University	<1 mi
Lung Microbiome and Inflammation in Early COPD	—	NYU Langone Health	<1 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD	Phase 2	Johns Hopkins University	<1 mi
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)	Phase 3	Hoffmann-La Roche	<1 mi
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.	N/A	Observational and Pragmatic Research Institute	<1 mi
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital	N/A	Fisher and Paykel Healthcare	<1 mi
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease	Phase 3	Hoffmann-La Roche	<1 mi
WTC Chest CT Imaging Archive	—	Icahn School of Medicine at Mount Sinai	<1 mi
PiMZ Longitudinal Cohort (PiMZ Logic)	—	Columbia University	<1 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	11 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)	Phase 3	AstraZeneca	13 mi
A Study to Evaluate Solrikitug in Participants With COPD (ZION)	Phase 2	Uniquity One (UNI)	17 mi
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease	N/A	University of Alabama at Birmingham	33 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening	—	Freenome Holdings Inc.	34 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	35 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD	Phase 2	Verona Pharma plc	35 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease	Phase 2	AstraZeneca	37 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.